Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-615-4 | CAS number: 108-78-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2009
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Scientific publication with appropriate description of the method.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
- Objective of study:
- other: placental transfer
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- In this study, the possibility of placental transfer of melamine and its effects on fetuses and pregnant dams were determined. Melamine was respectively administered at 0, 40 and 400 mg/kg body weight by daily gavage from gestation day (GD) 13 to GD 20 to control (C), low melamine (LM) and high melamine (HM) groups of pregnant female F344 rats. Rats were sacrificed 30 min after the last gavage.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Melamine
- EC Number:
- 203-615-4
- EC Name:
- Melamine
- Cas Number:
- 108-78-1
- Molecular formula:
- C3H6N6
- IUPAC Name:
- 1,3,5-triazine-2,4,6-triamine
- Details on test material:
- - Name of test material (as cited in study report): melamine- Analytical purity: minimum 99 %.- Producer: Wako Chemical Co. Tokyo.
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Ten- to twelve-week-old female and male F344 rats (150–200 g) were purchased from Japan SLC Inc., Shizuoka, Japan.
The rats were housed in plastic cages in a temperature and humidity-controlled room with a 12 h light/dark cycle with free access to water and food.
After an adaptation period of 1 week in the facilities, one or two female rats were housed with one male for mating. Vaginal plug check and vaginal smear observation by microscope were carried out each morning.
Day 0 of gestation (GD 0) was determined by the presence of a vaginal plug and/or spermatozoids in the vaginal smear. The female rat was then housed separately from the male and body weight (BW) was recorded daily.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on exposure:
- Pregnant dams were randomly divided into three groups (six rats per group): control (C), low melamine (LM), and high melamine (HM). The doses of melamine were based on the doses used by Dobson et al. (Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol. Sci. 106, 251–262, 2008).
Thus, from GD 13 to GD 20, 40 mg/kg BW and 400 mg/kg BW of melamine were, respectively, administered to LM and HM groups by gavage daily.
For control rats, 1 % carboxymethylcellulose solution (Wako Chemical Co., Tokyo, Japan), used to make the melamine suspension, was administered daily. - Duration and frequency of treatment / exposure:
- Gestation day GD 13 to GD 20, daily.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 - 40 - 400 mg/kg bw/day.
- No. of animals per sex per dose / concentration:
- 6 dams per group.
- Control animals:
- yes, concurrent vehicle
- Details on dosing and sampling:
- At GD 20, rats were sacrificed after isoflurane anesthetization, 30 min after the last gavage.
Blood was withdrawn from the inferior vena cava in a heparinized tube, centrifuged at 3000 g for 15 min, and the plasma was stored at -80 °C until analysis.
Amniotic fluid was sampled and the pups weighed.
Fetuses and placentas were frozen in liquid nitrogen and stored at -80 °C.
The study protocol was approved by Jichi Medical University Animal Care and Use Committee and the animals were maintained in accordance with the guidelines for the Care and Use of laboratory animals of Jichi Medical University. - Statistics:
- Statistical analysis was carried out using SPSS 11.0 software. Data are expressed as mean ± SD. Pair-wise comparisons were made between melamine groups and the control group. The minimum level of probability accepted for significance was P < 0.05.
Results and discussion
Main ADME results
- Type:
- distribution
- Results:
- It appears that melamine can cross the placental barrier and its transport is dose-dependent.
Toxicokinetic / pharmacokinetic studies
- Details on distribution in tissues:
- Melamine was not detected in the control samples. Melamine was present in both the LM and HM plasma samples; however, the concentration in the HM group was significantly higher than in the LM group. For amniotic fluid, melamine was detected only in the HM group. Melamine was present in the fetuses of both the LM and HM groups; however, the concentration was significantly higher in the HM group than in the LM group. Melamine was detected only in the placenta of the HM. It appears that melamine can cross the placental barrier and that its transport is dose-dependent.
The Table with the results is found below.
Any other information on results incl. tables
No significant differences were observed for dam BW, number of fetuses, or fetal and placental weights between the melamine groups and the control (P > 0.05).
Melamine concentration in plasma, amniotic fluid, fetus and placenta.
Groups |
Plasma (µg/ml) |
Amniotic fluid (µg/ml) |
Fetus (µg/g BW) |
Placenta (µg/g) |
C |
ND |
ND |
ND |
ND |
LM |
239.1 ± 39.6 |
ND |
327.7 ± 117.0 |
ND |
HM |
1413.7 ± 146.8* |
192.8 ± 30.0 |
570.0 ± 107.7* |
1117.7 ± 304.4 |
Values are expressed as mean ± SD, n= 6.
C: control group, LM: low melamine group, HM: high melamine group,
ND: not detected.
*P< 0.01.
Applicant's summary and conclusion
- Conclusions:
- Ingested melamine passes dose-dependently the placental barrier to reach the fetus.
- Executive summary:
In this study, the possibility of placental transfer of melamine and its effects on fetuses and pregnant dams were determined. Melamine was respectively administered at 0, 40 and 400 mg/kg body weight by daily gavage from gestation day (GD) 13 to GD 20 to control (C), low melamine (LM) and high melamine (HM) groups of pregnant female F344 rats. Rats were sacrificed 30 min after the last gavage. Melamine was not detected in any of the control and placental samples, or in amniotic fluid from the LM group. Plasma and fetal melamine concentrations in the HM group were significantly higher than in the LM group (P < 0.01).
These results show that ingested melamine dose-dependently passes the placental barrier to reach the fetus.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.